Comac Medical has conducted an assessment in IMP³rove – an instrument provided by the European Commission for measurement of the innovation potential of the company, which ranked the company among the growth champions in Europe.
IMP³rove assessment
October 19, 2015
Share:
News
With the ongoing evolution of global healthcare, identifying strategic locations for clinical trials has become a vital component...
As 2024 draws to a close, we take pride in reflecting on a year filled with progress, connections,...
Comac Medical is proud to announce the appointment of Peter Windisch as its new Chief Operations Officer (COO).